Texas Immunology, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 27
What Texas Immunology, Inc. makes
Texas Immunology, Inc. manufactures a range of diagnostic products including the FIRST SIGN, V-TREND QC TDM control serum, COUNT-10 TROL, and the V-TREND STREP A test. Their portfolio also includes the SERO/TEX LE, RF, and RPRL card tests, as well as the TARGET MYOGLOBIN, V-TREND TARGET IM, and V-TREND TARGET CRP tests, alongside DRUG CHECK and DRUG STOP testing kits.
The company is based in the United States and maintains a portfolio consisting of Class I, Class II, and U device classifications. These products are documented within the FDA 510(k) regulatory registry.
Catalogue
Search and filter all 27 devicesFrequently asked questions
How many devices does Texas Immunology, Inc. have in the registry?
The registry currently lists 27 devices for Texas Immunology, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Texas Immunology, Inc.'s devices?
Among its 27 most recently registered devices, Texas Immunology, Inc. has devices listed in FDA 510(k) (27 devices).
What risk classes do Texas Immunology, Inc.'s devices fall under?
Among its 27 most recently registered devices, the classes recorded for Texas Immunology, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Texas Immunology, Inc. in the registry?
The most recently registered devices listed for Texas Immunology, Inc. include FIRST SIGN, V-TREND QC TDM CONTROL SERUM 1, 2, 3., COUNT-10 TROL and V-TREND STREP A TEST.